News

29.06.2016

EPF: Successful conclusion of Patient Empowerment campaign

EMSP’s partners from the European Patients’ Forum (EPF) concluded their one-year awareness-raising Patient Empowerment campaign with a high-level policy roundtable…

Swiss MS Day: Launch of national MS register

29.06.2016

EMSP’s members from the Swiss MS Society marked the Swiss MS Day, 25 June, with a multi-stakeholder event organised in…

EPF: Successful conclusion of Patient Empowerment campaign

29.06.2016

EMSP’s partners from the European Patients’ Forum (EPF) concluded their one-year awareness-raising Patient Empowerment campaign with a high-level policy roundtable…

23.06.2016

EU and US enhance collaboration on patient involvement in medicines development

The European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) have agreed to set up a forum…

EU and US enhance collaboration on patient involvement in medicines development

23.06.2016

The European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) have agreed to set up a forum…

RiMS: Course on rehabilitation in multiple sclerosis

13.06.2016

EMSP’s partners from Rehabilitation in MS (RiMS) are endorsing a residential course on rehabilitation in multiple sclerosis (MS) which will…

13.06.2016

RiMS: Course on rehabilitation in multiple sclerosis

EMSP’s partners from Rehabilitation in MS (RiMS) are endorsing a residential course on rehabilitation in multiple sclerosis (MS) which will…

IMPRESS study: Focus on people with MS and their carers

31.05.2016

The London School of Economics (LSE) is currently leading a study –  IMPRESS – which explores the social economic costs, quality of life and…

IMPRESS study: Focus on people with MS and their carers

31.05.2016

The London School of Economics (LSE) is currently leading a study –  IMPRESS – which explores the social economic costs, quality of life and…

1 43 44 45 46 47 69